Big data and cardiovascular disease research: opportunities in the Farr Institute



Similar documents
Big data and connected challenges in cardiovascular health

Big health data: perspectives across the patient journey from linking multiple record sources

Prognosis research: new opportunities in linked electronic health records

Challenges and opportunities of combining linked primary and secondary care data from EHR into i2b2

Big data, e health and the Farr Institute

Dundee e-health Centre of Excellence

Research Skills for Non-Researchers: Using Electronic Health Data and Other Existing Data Resources

Big Data for Population Health

Farr Institute of Health Informatics Research Harnessing Data for Health Science and e-health Innovation

Data platforms to support research, evaluation & practice. David V Ford Professor of Health Informatics School of Medicine, Swansea University

Informatics: Opportunities & Applications. Professor Colin McCowan Robertson Centre for Biostatistics and Glasgow Clinical Trials Unit

Main Effect of Screening for Coronary Artery Disease Using CT

RESEARCH ASSISTANT (DATA ANALYST / STATISTICIAN) THE CALIBER PROGRAMME

DISCLOSURES RISK ASSESSMENT. Stroke and Heart Disease -Is there a Link Beyond Risk Factors? Daniel Lackland, MD

MISSING DATA ANALYSIS AMONG PATIENTS IN THE PINNACLE REGISTRY

NIHI Big Data in Healthcare Research Case Study

RISK STRATIFICATION for Acute Coronary Syndrome in the Emergency Department

Coronary Artery Disease leading cause of morbidity & mortality in industrialised nations.

Big Data for Population Health and Personalised Medicine through EMR Linkages

ADVANCE: a factorial randomised trial of blood pressure lowering and intensive glucose control in 11,140 patients with type 2 diabetes

Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1 9 million people

The National Service Framework for Cardiac Disease: Strategic Aims and Implementation A Cardiac Work Programme for Wales

Using 'Big Data' to Estimate Benefits and Harms of Healthcare Interventions

Redefining the NSTEACS pathway in London

Technical Issues in Aggregating and Analyzing Data from Heterogeneous EHR Systems

Malmö Preventive Project. Cardiovascular Endpoints

Rivaroxaban for acute coronary syndromes

Cardiovascular Endpoints

Translational research facilitating experimental medicine in dementia in the UK

Malmö Preventive Project. Cardiovascular Endpoints

Cardiovascular Endpoints

CARDIAC REHABILITATION

4/7/2015. Cardiac Rehabilitation: From the other side of the glass door. Chicago, circa Objectives. No disclosures, no conflicts

Your Guide to Express Critical Illness Insurance Definitions

Randomized trials versus observational studies

Research strategy and capacity development in population health science: an MRC and personal view

Māori Pathways to and Through Health Care for STEMIs in New Zealand. Summer Studentship Research by Ellie Tuzzolino- Smith

Quantifying Life expectancy in people with Type 2 diabetes

MANAGEMENT OF LIPID DISORDERS: IMPLICATIONS OF THE NEW GUIDELINES

Table 1 Performance Measures. Quality Monitoring P4P Yr1 Yr2 Yr3. Specification Source. # Category Performance Measure

Priority setting for research in healthcare: an application of value of. information analysis to glycoprotein IIb/IIIa antagonists in non-st elevation

Data, Outcomes and Population Health Management. CPPEG January 2016

The impact and future of QOF in the UK

Digital Health: Catapulting Personalised Medicine Forward STRATIFIED MEDICINE

Demonstrating Meaningful Use Stage 1 Requirements for Eligible Providers Using Certified EMR Technology

EMR Tutorial Acute Coronary Syndrome

Introduction to genetic testing and pharmacogenomics

GENERAL HEART DISEASE KNOW THE FACTS

URN: Family name: Given name(s): Address:

Saving healthcare costs by implementing new genetic risk tests for early detection of cancer and prevention of cardiovascular diseases

Tackling the Challenges of Big Data! Tackling The Challenges of Big Data. My Research Group. John Guttag. John Guttag. Big Data Analytics

Preparing for the Collection and Use of External Family History and Genetic Test Result Data

Investor science conference call: American College of Cardiology 2015

Radiology Business Management Association Technology Task Force. Sample Request for Proposal

UK Biobank. Integrating electronic health records into the UK Biobank Resource. Version

Medicare & Medicaid EHR Incentive Program Meaningful Use Stage 1 Requirements Summary.

Listen to your heart: Good Cardiovascular Health for Life

CARDIAC CARE. Giving you every advantage

THE INTERNET STROKE CENTER PRESENTATIONS AND DISCUSSIONS ON STROKE MANAGEMENT

6/5/2014. Objectives. Acute Coronary Syndromes. Epidemiology. Epidemiology. Epidemiology and Health Care Impact Pathophysiology

Secure networking and AAAI

Standardized Representation for Electronic Health Record-Driven Phenotypes

Manitoba EMR Data Extract Specifications

Innovation Platform: Sudden Cardiac Death

Prognostic impact of uric acid in patients with stable coronary artery disease

A Multi-locus Genetic Risk Score for Abdominal Aortic Aneurysm

Post discharge tariffs in the English NHS

Validation and Replication

Mar. 31, 2011 (202) Improving Quality of Care for Medicare Patients: Accountable Care Organizations

Journal Club: Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy by the AIM-HIGH Investigators

Disclosures. The FAST-MI registry is a registry of the French Society of Cardiology, supported by unrestricted grants from:

Translating Science to Health Care: the Use of Predictive Models in Decision Making

A PATIENT S GUIDE TO SECONDARY PREVENTION IN ACUTE CORONARY SYNDROME (ACS)

Electronic Medical Records and Genomics: Possibilities, Realities, Ethical Issues to Consider

Project 2: Evaluating the impact of cholesterol measures on risk of subsequent events in patients with established coronary heart disease

Performance Measurement for the Medicare and Medicaid Eligible (MME) Population in Connecticut Survey Analysis

Carolina s Journey: Turning Big Data Into Better Care. Michael Dulin, MD, PhD

International Task Force for Prevention Of Coronary Heart Disease. Clinical management of risk factors. coronary heart disease (CHD) and stroke

SOUTH EAST WALES CARDIAC NETWORK INTEGRATED CARE PATHWAY CARDIAC REHABILITATION MAY 2005

Meaningful Use: Registration, Attestation, Workflow Tips and Tricks

NAME OF THE HOSPITAL: 1. Coronary Balloon Angioplasty: M7F1.1/ Angioplasty with Stent(PTCA with Stent): M7F1.3

Clinical Audit in Hospital Authority. Dr Betty Young Convenor for Clinical Audit, Hospital Authority

COMMITTEE FOR HUMAN MEDICINAL PRODUCTS (CHMP) DRAFT GUIDELINE ON THE EVALUATION OF MEDICINAL PRODUCTS FOR CARDIOVASCULAR DISEASE PREVENTION

PROGRAM ASSISTANCE LETTER

Bayer Pharma AG Berlin Germany Tel News Release. Not intended for U.S. and UK Media

DIAGNOSTIC CRITERIA OF STROKE

Introduction to Information and Computer Science: Information Systems

DH Cardiac Rehabilitation Commissioning Pack: highlights and process. Prof Patrick Doherty BACR conference Liverpool 2010

Key Features and Terms and Conditions of Family Life Insurance

Big data size isn t enough! Irene Petersen, PhD Primary Care & Population Health

Threats and Opportunities the Scientific Challenges of the 21 st Century

HEdis Code Quick Reference Guide Disease Management Services

3/2/2010 Post CABG R h e bili a i tat on Ahmed Elkerdany Professor o f oof C ardiac Cardiac Surgery Ain Shams University 1

FFR CT : Clinical studies

2013 ACO Quality Measures

Electronic Health Record (EHR) Data Analysis Capabilities

COST OF SKIN CANCER IN ENGLAND MORRIS, S., COX, B., AND BOSANQUET, N.

How can registries contribute to guidelines? Nicolas DANCHIN, HEGP, Paris

Future National Clinical Priorities for Ambulance Services in England

Transcription:

Big data and cardiovascular disease research: opportunities in the Farr Institute The Henderson Lecture Welsh Cardiovascular Society Cardiff 15 May 2014 Harry Hemingway FFPH, FRCP Professor of Clinical Epidemiology, UCL Director of Farr Institute, London www.farrinstitute.org/

Wales and record linkages and registries for health On the world stage SAIL and now Farr Institute Ronan Lyons, David Ford and team www.farrinstitute.org/ In cardiovascular Julian Halcox, Clive Weston

Delivery theme 5: Improving Information Delivery theme 6: Targetting research

Cardiovascular diseases global #1 Cause of death/premature death/disability adjusted life years So what has gone wrong? wrong prevention wrong treatments wrong diagnoses / wrong names for diseases wrong health systems (and too costly) wrong relations to data, information and knowledge wrong relations with patients wrong science! (done by the wrong people!)

Might big data help right these wrongs?

Yes! Mike Lauer, Director Division of Cardiovascular Sciences NIH-NHLBI JAMA 2012

Yes! Eric Topol wireless and genomic medicine

Big data like teenage sex everyone talks about it, nobody really knows how to do it, everyone thinks everyone else is doing it, so everyone claims they are doing it Dan Ariely

What is big data? Population = all 10 7 Ages = all Diseases = all 10 4 Longitudinal clinical phenotyping = all Clinical laboratory values = all 10 3 Drugs = all 10 3 Genomic variation = whole genome sequencing sensed self social media society

What is big data Xx figure from BarbabasiA. NEJM2007;357:404-7An Increasingly Complex Barbabasi A. NEJM2007;357:404-7An

Pace and scale of translation Discovery Public health and clinical decisions health gain Big data / Health records Trials Outcomes & quality research

Clinical data collected at the time of angiography in 1996/7 paper based, moth eaten, non-standardised, guessed (digit preference), lost, illegible, printed out from different electronic systems etc.. new and untrumpeted linked to forerunner of Hospital Episode statistics for outcomes

Discovery

Genomics 500k participants, 47 baseline biomarkers and custom gene array data available in 2014, cardiac and brain imaging in 100k underway Open access Scalable approaches to disease phenotypes (startpoints or endpoints) based on linked electronic health record resources - cardiac - diabetes - stroke - cancer Example of Farr Institute working across Wales, Scotland and England

Genetic variants identified from genome wide association studies: Phenotype largely not from EHR, Studied one at a time. Do these associations replicate on phenome wide association studies using EHR?

EHR and genomics for discovery Reliability of e-mr phenotypes: replication of GWAS Denny JC et al. Nat Biotechnol. 2013 Nov 24;31(12):1102 1111

Discovering new risk factor associations: CVD aggregates vs specific diseases Are the risk factors the same?

To answer this question reliably we need Scale: e.g. >1 million adults followed for 5 years Phenotypic resolution: Baseline risk factors Follow up for disease outcomes Cost to research funder of such data collection?

0.00

The research costs are substantial Information governance Store, share, harmonise, analyse EHR data..with scalable tools And develop pool of clinical expertise

Multiple Record Linkages needs expansion across NICOR registries

Four nationwide EHR sources linked Healthy, GP registration Stable angina Pneumonia hospitalization Myocardial infarction hospitalization See GP for follow-up Death Patient s experience Primary care New patient check: blood pressure, smoking status, alcohol use etc. Diagnosis of stable angina. Blood tests (e.g. cholesterol). Prescription of aspirin, nitrates etc. Diagnosis of myocardial infarction Blood tests, blood pressure. Prescriptions of beta blocker, statin, ACEi etc. Time Sudden death Hospitalization (HES) Admit / discharge dates. Primary diagnosis: Viral pneumonia, not elsewhere classified Admit / discharge dates. Primary diagnosis: Acute myocardial infarction Procedure: Percutaneous coronary intervention Disease Registry (MINAP) ECG, cardiac markers. Diagnosis: STEMI Death Census (ONS) Date of death. Cause: 1) Rupture of abdominal aortic aneurysm 2) Old myocardial infarction Denaxas et al, Data Resource Profile: CALIBER, Intl Journal Epidemiology, 2012

What does linked record data look like?

need tools

How to define phenotypes using multiple EHR data sources?

1001, 2000-01-01, 23,1,NULL,I48 1001, 1994-08-11,1234,1,3,7L1H300 1001, 1993-01-01, 253,1,1,793Mz00 1231, 2012-03-03, 23,1,123,K65 1121, 2013-05-04, 7,1,3,5,14AN.00 1121, 2011-05-21, 81,1,9, G573100 1511, 1993-01-11, 91,1,6,9hF1.00 1511, 199-03-11, 91,1,6, G573100 9913, 2012-05-21, 81,1,9, G573100 67222, 1994-11-01,1234,1,3,7L1H300 67222, 1995-12-21,1234,1,3,7L1H300 67222, 1991-03-03,1234,1,3,7L1H310 682444, 1993-01-01, 253,1,1,793Mz00 1001, 2000-01-01, af_gprd=1 1231, 2012-03-03, af_hes=3 1121, 2013-05-04, af_procs_gprd=1 1511, 1993-01-11, heart_valve_gprd=2 9913, 2012-05-21, af_hes=1 67222, 1994-08-11, af_hes=1 682444, 1993-01-01, heart_valve_hes=2 af=1, af_diag_source= primary care af_diag_date=2001-12-01

AF algorithm

CALIBER Data Portal Online data discovery tool caliberresearch.org Access to all CALIBER phenotypes, algorithms and implementation details and scripts (SQL,R, Stata) 45 users, 4 institutions, 538 phenotypes, >15,000 clinical diagnostic codes curated Standardization Frontend is ICD10, backend becoming SNOMED-CT, LOINC A community rather than a static resource Researchers contribute phenotypes and algorithms Other researchers validate/enhance/correct them

Engaging clinicians in EHR phenotyping.is proving a route in for many academically minded clinicians at early, mid and late career stages

back to our question. 12 CVDs: common risk

Inverse, weak and strong what s the risk factor? 10 million person years follow-up --- = Composite CVD Rapsomaniki, George et al CALIBER 2013

Inverse, null, weak and strong what s the risk factor? Shah et al CALIBER under review

Higher resolution epidemiology: blood pressure and 12 cardiovascular diseases Cohort N 2 million adults, >100,000 disease events Myocardial infarction Abdominal aortic aneurysm Confirms what we know from combining multiple expensive studies Adds resolution CALIBER Rapsomaniki et al 2014, Lancet in press

Blood pressure and 12 cardiovascular diseases CALIBER Rapsomaniki et al 2014, Lancet in press

Higher resolution approaches: implications Disease mechanism Trial design Screening and risk prediction

Discovery Trials

Developing informatics platforms for stratified trials

Discovery Trials Outcomes research/real world evidence

Temporal resolution.cardiologists can study both Onset Prognosis Healthy Onset of first cardiovascular disease Second cardiovascular disease, death

Prognosis research: opportunities in EHR PROGRESS 1: A framework for researching clinical outcomes BMJ. 2013 Feb 5;346:e5595. PROGRESS 2: Prognostic Factor Research PLoS Med. 2013 Feb;10(2):e1001380. PROGRESS 3: Prognostic Model Research PLoS Med. 2013 Feb; 10(2):e1001381. PROGRESS 4: Stratified Medicine Research BMJ. 2013 Feb 5;346:e5793.

Outcomes research: capturing clinically meaningful complexity one startpoint to many types of endpoint

Real world prognosis of stable CAD (n=102, 023) and 5 yr risk of coronary death + non-fatal MI (n=8,856) A gold standard for estimating relevant risks? Rapsomaniki et al CALIBER EHJ 2013

Prognostic models using linked EHR: Which clinically recorded factors add to discrimination? Origin of data is EHR therefore implementation of risk prediction models in decision support tools (with evaluation) is feasible Rapsomaniki et al CALIBER EHJ 2013

Discovery Trials Outcomes research/real world evidence Public Health

Outcomes assessment: importance of linking multiple record sources Herrett, Shah et al CALIBER BMJ 2013

How does CVD first present? In the real world, today Abdominal aortic aneurysm 2% Intracerebral haemorrhage 2% Subarachnoid haemorrhage 1% Ventricular arrhythmia/sudden cardiac death 3% MI/Fatal CHD 18% Unstable angina 5% CHD 10% Ischaemic stroke 13% Peripheral arterial disease 11% CALIBER 2014, under review Transient ischaemic attack 11% Heart failure 12% Stable angina 12% N=1.93 million patients >110K CVD events 5 year median follow-up

Strengthening health informatics research MRC coordinated 10-partner 19m call for e-health informatics research centres across the UK Cutting edge research using data linkage capacity building Additional 20m capital to create Farr Institute UK Health Informatics Research Network Coordinate training, share good practice and develop methodologies Engage with the public, collaborate with industry and the NHS Farr London Farr Scotland Farr at Swansea, Wales Farr N8, Manchester

Rapid evolution of initiatives: emphasis on infrastructure JULY 2013 JULY 2013 OCTOBER 2013 November 2013 Health Informatics Collaboration (sharing hospital data across 5 Biomedical Research Centres) February 2014 Medical Bioinformatics Awards..needs cardiovascular co-ordination

Clinical data: 1996/7 paper based, moth eaten, non-standardised, guessed (digit preference), lost, illegible, printed out from different electronic systems etc.. 2014?..and in

Cardiology data submerged in diverse information systems: EDC Medcon ICHIS Discharge Letter Prescription Episodes Patients Procedure details Inpatients Outpatients GE MRI/MRA scan data Error tables DQtable s Error tables DQtable s APC data Error tables Appointment data CIS Prosolve Investigations/ Diagnosis/ Measurements APC/Discharg es DQtable s Referred/A&E admissions Referred/A&E appointments Appointments Pathology ACS PMI A&E ACS A&E PACS ACS data transformation Output Tables Demographics Investigation Comorbidities Intervention Admissions Appointments Outcome Discharge External Data (e.g. HSCIC) Query Tool Extract Tables (NIHR HIC dataset) Demographics Investigation Comorbidities Intervention Admissions Appointments Outcome Discharge

Drought Data Need much wider national record linkages CPRD-NICOR-HES Need to liberate submerged deeper hospital phenotypes Need to converge EHR, omics and imaging Tools Health informatics 20 years behind bioinformatics People (re) building public trust in the wake of care.data Not nearly enough clinicians with the training and opportunity to drive improvements in care (and research) through data, information and knowledge (400 US clinicians in new board certified specialty JAMA 2014)

Farr and CALIBER cardiovascular collaborators Mike Barnes, Mark Caulfield, Sheng-Chia Chung, John Deanfield, Spiros Denaxas, Chris Gale, Aroon Hingorani, Mar Pujades, Eleni Rapsomaniki, Anoop Shah, Liam Smeeth, Adam Timmis among others

Wales, SAIL, CIPHER and the Welsh Farr node Wales is on the world stage in record linkages The funding environment is currently permissive (Wales representation at BHF/MRC/WT cardiovascular informatics workshop) So whatever stage of the translational cycle and informatics cycle you are interested in. Get involved! www.farrinstitute.org/ -